A case-study for Poland.
A presentation on the relation between patient representatives and the European Medicines Agency (EMA).
EMSP’s Chief Executive Christoph Thalheim presented at an MS debate hosted in the European Parliament on 10 November 2015.
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.